These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4093187)

  • 1. Evaluating and planning screening programmes.
    Parkin DM; Day NE
    IARC Sci Publ; 1985; (66):45-63. PubMed ID: 4093187
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer incidence in Finland, Iceland, Norway and Sweden. A comparative study.
    Ringertz N
    Acta Pathol Microbiol Scand Suppl; 1971; 224():Suppl 224:1-95. PubMed ID: 4340100
    [No Abstract]   [Full Text] [Related]  

  • 3. The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995.
    Sigurdsson K
    Acta Obstet Gynecol Scand; 1999 Jul; 78(6):478-85. PubMed ID: 10376856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes.
    Lăără E; Day NE; Hakama M
    Lancet; 1987 May; 1(8544):1247-9. PubMed ID: 2884378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cancer registry in cancer control.
    Saxén EA
    Arch Geschwulstforsch; 1984; 54(5):403-8. PubMed ID: 6497585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cervical cancer screening in Scandinavia.
    Day NE
    Obstet Gynecol; 1984 May; 63(5):714-8. PubMed ID: 6717876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mass screening for cancer of the uterine cervix in the country of Frederiksborg. Preliminary evaluation of a centrally controlled system adapted to a selected age group].
    Larsen E; Hou-Jensen K
    Ugeskr Laeger; 1975 Jul; 137(27):1555-7. PubMed ID: 1145870
    [No Abstract]   [Full Text] [Related]  

  • 8. [Screening for cancer].
    Bjørge T; Tropé CG; Engeland A
    Tidsskr Nor Laegeforen; 1999 Mar; 119(8):1129-36. PubMed ID: 10228417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers.
    Pukkala E; Andersen A; Berglund G; Gislefoss R; Gudnason V; Hallmans G; Jellum E; Jousilahti P; Knekt P; Koskela P; Kyyrönen PP; Lenner P; Luostarinen T; Löve A; Ogmundsdóttir H; Stattin P; Tenkanen L; Tryggvadóttir L; Virtamo J; Wadell G; Widell A; Lehtinen M; Dillner J
    Acta Oncol; 2007; 46(3):286-307. PubMed ID: 17450464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Planning services for the cancer patient.
    Wrighton RJ
    IARC Sci Publ; 1985; (66):75-85. PubMed ID: 3912325
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cervical cancer and mass screening].
    Hakama M
    Duodecim; 1970; 86(5):270-6. PubMed ID: 5421372
    [No Abstract]   [Full Text] [Related]  

  • 12. [Update in epidemiology].
    Hill C; Doyon F
    Bull Cancer; 1998 Jan; 85(1):63-5. PubMed ID: 9752352
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Carcinoma of the uterine cervix and mass screening].
    Timonen S; Nieminen U
    Duodecim; 1970; 86(5):277-84. PubMed ID: 5421373
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative evaluation of the malignant neoplasm morbidity of the population in selected territories of the USSR and Finland].
    Merabishvili VM; Khakulinen T; Serova LS
    Vopr Onkol; 1986; 32(6):23-8. PubMed ID: 3727479
    [No Abstract]   [Full Text] [Related]  

  • 16. Multisite cancer screening: a cancer control experience in secondary prevention.
    Pearson DK; Rodes ND; Blackwell CW; Perez-Mesa CM
    Mo Med; 1981 Dec; 78(12):740-2, 745. PubMed ID: 7339483
    [No Abstract]   [Full Text] [Related]  

  • 17. Statistical studies in the aetiology of malignant neoplasms. 3.
    Clemmesen J
    Acta Pathol Microbiol Scand Suppl; 1969; 209():Suppl 209:1+. PubMed ID: 5267218
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical breast examination as a supplement to mass screening for cervical cancer.
    Bostofte E; Berg O; Serup J
    Dan Med Bull; 1981 Aug; 28(3):100-2. PubMed ID: 7273864
    [No Abstract]   [Full Text] [Related]  

  • 19. [Screening for cancer: from guidelines to practice].
    Sasco AJ
    Bull Cancer; 2001 Jul; 88(7):643-4. PubMed ID: 11495814
    [No Abstract]   [Full Text] [Related]  

  • 20. [Epidemiologic cancer research].
    Saxén E; Hakama M; Teppo L
    Duodecim; 1974; 90(22):1597-604. PubMed ID: 4452329
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.